Mifamurtide in Metastatic and Recurrent Osteosarcoma: A Patient Access Study with Pharmacokinetic, Pharmacodynamic, and Safety Assessments

PURPOSE: This non-randomized, patient-access protocol, assessed both safety and efficacy outcomes following liposomal muramyl –tripeptide-phosphatidylethanolamine (L-MTP-PE; mifamurtide) in patients with high-risk, recurrent and/or metastatic osteosarcoma. METHODS: Patients received mifamurtide 2 mg...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Blood Cancer
Egile Nagusiak: Anderson, P.M., Meyers, P., Kleinerman, E., Venkatakrishnan, K., Hughes, D.P., Herzog, C., Huh, W., Sutphin, R., Vyas, Y. M., Shen, V., Warwick, A., Yeager, N., Oliva, C., Wang, B., Liu, Y., Chou, A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533988/
https://ncbi.nlm.nih.gov/pubmed/23997016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24686
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak